Cannabinoids are found in the cannabis plant, they can be produced in biosynthesis way. While biosynthesis has not yet proven itself as a scalable technology, it has the potential to radically alter the way cannabinoids are manufactured in the near future.These compounds are the exact same as what cannabis expresses.

The global Biosynthesis of Cannabinoids market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.

North American market for Biosynthesis of Cannabinoids is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

Asia-Pacific market for Biosynthesis of Cannabinoids is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

The global market for Biosynthesis of Cannabinoids in Food Industry is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

The major global companies of Biosynthesis of Cannabinoids include Anandia Laboratories, Gingko Bioworks, Hyasynth Bio, InMed Pharmaceuticals, Librede, Renew Biopharma, Cronos Group, Organigram and Teewinot Life Sciences, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.

This report aims to provide a comprehensive presentation of the global market for Biosynthesis of Cannabinoids, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Biosynthesis of Cannabinoids.

Report Scope

The Biosynthesis of Cannabinoids market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Biosynthesis of Cannabinoids market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Biosynthesis of Cannabinoids companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Biosynthesis of Cannabinoids Market Report

Report Metric	Details
Report Name	Biosynthesis of Cannabinoids Market
Segment by Type	THC CBD Others
Segment by Application	Food Industry Medical Industry Others
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Anandia Laboratories, Gingko Bioworks, Hyasynth Bio, InMed Pharmaceuticals, Librede, Renew Biopharma, Cronos Group, Organigram, Teewinot Life Sciences, ICC International Cannabis Corp., Biotii Technologies Corp., Bristol-Myers Squibb, Biogen Inc., GW Pharmaceuticals
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Biosynthesis of Cannabinoids companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Biosynthesis of Cannabinoids Market report?

Ans: The main players in the Biosynthesis of Cannabinoids Market are Anandia Laboratories, Gingko Bioworks, Hyasynth Bio, InMed Pharmaceuticals, Librede, Renew Biopharma, Cronos Group, Organigram, Teewinot Life Sciences, ICC International Cannabis Corp., Biotii Technologies Corp., Bristol-Myers Squibb, Biogen Inc., GW Pharmaceuticals

What are the Application segmentation covered in the Biosynthesis of Cannabinoids Market report?

Ans: The Applications covered in the Biosynthesis of Cannabinoids Market report are Food Industry, Medical Industry, Others

What are the Type segmentation covered in the Biosynthesis of Cannabinoids Market report?

Ans: The Types covered in the Biosynthesis of Cannabinoids Market report are THC, CBD, Others

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Biosynthesis of Cannabinoids Market Size Growth Rate by Type: 2019 VS 2023 VS 2030

1.2.2 THC

1.2.3 CBD

1.2.4 Others

1.3 Market by Application

1.3.1 Global Biosynthesis of Cannabinoids Market Growth by Application: 2019 VS 2023 VS 2030

1.3.2 Food Industry

1.3.3 Medical Industry

1.3.4 Others

1.4 Study Objectives

1.5 Years Considered

1.6 Years Considered

2 Global Growth Trends

2.1 Global Biosynthesis of Cannabinoids Market Perspective (2019-2030)

2.2 Biosynthesis of Cannabinoids Growth Trends by Region

2.2.1 Global Biosynthesis of Cannabinoids Market Size by Region: 2019 VS 2023 VS 2030

2.2.2 Biosynthesis of Cannabinoids Historic Market Size by Region (2019-2024)

2.2.3 Biosynthesis of Cannabinoids Forecasted Market Size by Region (2025-2030)

2.3 Biosynthesis of Cannabinoids Market Dynamics

2.3.1 Biosynthesis of Cannabinoids Industry Trends

2.3.2 Biosynthesis of Cannabinoids Market Drivers

2.3.3 Biosynthesis of Cannabinoids Market Challenges

2.3.4 Biosynthesis of Cannabinoids Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Biosynthesis of Cannabinoids Players by Revenue

3.1.1 Global Top Biosynthesis of Cannabinoids Players by Revenue (2019-2024)

3.1.2 Global Biosynthesis of Cannabinoids Revenue Market Share by Players (2019-2024)

3.2 Global Biosynthesis of Cannabinoids Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Players Covered: Ranking by Biosynthesis of Cannabinoids Revenue

3.4 Global Biosynthesis of Cannabinoids Market Concentration Ratio

3.4.1 Global Biosynthesis of Cannabinoids Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Biosynthesis of Cannabinoids Revenue in 2023

3.5 Biosynthesis of Cannabinoids Key Players Head office and Area Served

3.6 Key Players Biosynthesis of Cannabinoids Product Solution and Service

3.7 Date of Enter into Biosynthesis of Cannabinoids Market

3.8 Mergers & Acquisitions, Expansion Plans

4 Biosynthesis of Cannabinoids Breakdown Data by Type

4.1 Global Biosynthesis of Cannabinoids Historic Market Size by Type (2019-2024)

4.2 Global Biosynthesis of Cannabinoids Forecasted Market Size by Type (2025-2030)

5 Biosynthesis of Cannabinoids Breakdown Data by Application

5.1 Global Biosynthesis of Cannabinoids Historic Market Size by Application (2019-2024)

5.2 Global Biosynthesis of Cannabinoids Forecasted Market Size by Application (2025-2030)

6 North America

6.1 North America Biosynthesis of Cannabinoids Market Size (2019-2030)

6.2 North America Biosynthesis of Cannabinoids Market Growth Rate by Country: 2019 VS 2023 VS 2030

6.3 North America Biosynthesis of Cannabinoids Market Size by Country (2019-2024)

6.4 North America Biosynthesis of Cannabinoids Market Size by Country (2025-2030)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Biosynthesis of Cannabinoids Market Size (2019-2030)

7.2 Europe Biosynthesis of Cannabinoids Market Growth Rate by Country: 2019 VS 2023 VS 2030

7.3 Europe Biosynthesis of Cannabinoids Market Size by Country (2019-2024)

7.4 Europe Biosynthesis of Cannabinoids Market Size by Country (2025-2030)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Biosynthesis of Cannabinoids Market Size (2019-2030)

8.2 Asia-Pacific Biosynthesis of Cannabinoids Market Growth Rate by Region: 2019 VS 2023 VS 2030

8.3 Asia-Pacific Biosynthesis of Cannabinoids Market Size by Region (2019-2024)

8.4 Asia-Pacific Biosynthesis of Cannabinoids Market Size by Region (2025-2030)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Biosynthesis of Cannabinoids Market Size (2019-2030)

9.2 Latin America Biosynthesis of Cannabinoids Market Growth Rate by Country: 2019 VS 2023 VS 2030

9.3 Latin America Biosynthesis of Cannabinoids Market Size by Country (2019-2024)

9.4 Latin America Biosynthesis of Cannabinoids Market Size by Country (2025-2030)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Biosynthesis of Cannabinoids Market Size (2019-2030)

10.2 Middle East & Africa Biosynthesis of Cannabinoids Market Growth Rate by Country: 2019 VS 2023 VS 2030

10.3 Middle East & Africa Biosynthesis of Cannabinoids Market Size by Country (2019-2024)

10.4 Middle East & Africa Biosynthesis of Cannabinoids Market Size by Country (2025-2030)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Anandia Laboratories

11.1.1 Anandia Laboratories Company Detail

11.1.2 Anandia Laboratories Business Overview

11.1.3 Anandia Laboratories Biosynthesis of Cannabinoids Introduction

11.1.4 Anandia Laboratories Revenue in Biosynthesis of Cannabinoids Business (2019-2024)

11.1.5 Anandia Laboratories Recent Development

11.2 Gingko Bioworks

11.2.1 Gingko Bioworks Company Detail

11.2.2 Gingko Bioworks Business Overview

11.2.3 Gingko Bioworks Biosynthesis of Cannabinoids Introduction

11.2.4 Gingko Bioworks Revenue in Biosynthesis of Cannabinoids Business (2019-2024)

11.2.5 Gingko Bioworks Recent Development

11.3 Hyasynth Bio

11.3.1 Hyasynth Bio Company Detail

11.3.2 Hyasynth Bio Business Overview

11.3.3 Hyasynth Bio Biosynthesis of Cannabinoids Introduction

11.3.4 Hyasynth Bio Revenue in Biosynthesis of Cannabinoids Business (2019-2024)

11.3.5 Hyasynth Bio Recent Development

11.4 InMed Pharmaceuticals

11.4.1 InMed Pharmaceuticals Company Detail

11.4.2 InMed Pharmaceuticals Business Overview

11.4.3 InMed Pharmaceuticals Biosynthesis of Cannabinoids Introduction

11.4.4 InMed Pharmaceuticals Revenue in Biosynthesis of Cannabinoids Business (2019-2024)

11.4.5 InMed Pharmaceuticals Recent Development

11.5 Librede

11.5.1 Librede Company Detail

11.5.2 Librede Business Overview

11.5.3 Librede Biosynthesis of Cannabinoids Introduction

11.5.4 Librede Revenue in Biosynthesis of Cannabinoids Business (2019-2024)

11.5.5 Librede Recent Development

11.6 Renew Biopharma

11.6.1 Renew Biopharma Company Detail

11.6.2 Renew Biopharma Business Overview

11.6.3 Renew Biopharma Biosynthesis of Cannabinoids Introduction

11.6.4 Renew Biopharma Revenue in Biosynthesis of Cannabinoids Business (2019-2024)

11.6.5 Renew Biopharma Recent Development

11.7 Cronos Group

11.7.1 Cronos Group Company Detail

11.7.2 Cronos Group Business Overview

11.7.3 Cronos Group Biosynthesis of Cannabinoids Introduction

11.7.4 Cronos Group Revenue in Biosynthesis of Cannabinoids Business (2019-2024)

11.7.5 Cronos Group Recent Development

11.8 Organigram

11.8.1 Organigram Company Detail

11.8.2 Organigram Business Overview

11.8.3 Organigram Biosynthesis of Cannabinoids Introduction

11.8.4 Organigram Revenue in Biosynthesis of Cannabinoids Business (2019-2024)

11.8.5 Organigram Recent Development

11.9 Teewinot Life Sciences

11.9.1 Teewinot Life Sciences Company Detail

11.9.2 Teewinot Life Sciences Business Overview

11.9.3 Teewinot Life Sciences Biosynthesis of Cannabinoids Introduction

11.9.4 Teewinot Life Sciences Revenue in Biosynthesis of Cannabinoids Business (2019-2024)

11.9.5 Teewinot Life Sciences Recent Development

11.10 ICC International Cannabis Corp.

11.10.1 ICC International Cannabis Corp. Company Detail

11.10.2 ICC International Cannabis Corp. Business Overview

11.10.3 ICC International Cannabis Corp. Biosynthesis of Cannabinoids Introduction

11.10.4 ICC International Cannabis Corp. Revenue in Biosynthesis of Cannabinoids Business (2019-2024)

11.10.5 ICC International Cannabis Corp. Recent Development

11.11 Biotii Technologies Corp.

11.11.1 Biotii Technologies Corp. Company Detail

11.11.2 Biotii Technologies Corp. Business Overview

11.11.3 Biotii Technologies Corp. Biosynthesis of Cannabinoids Introduction

11.11.4 Biotii Technologies Corp. Revenue in Biosynthesis of Cannabinoids Business (2019-2024)

11.11.5 Biotii Technologies Corp. Recent Development

11.12 Bristol-Myers Squibb

11.12.1 Bristol-Myers Squibb Company Detail

11.12.2 Bristol-Myers Squibb Business Overview

11.12.3 Bristol-Myers Squibb Biosynthesis of Cannabinoids Introduction

11.12.4 Bristol-Myers Squibb Revenue in Biosynthesis of Cannabinoids Business (2019-2024)

11.12.5 Bristol-Myers Squibb Recent Development

11.13 Biogen Inc.

11.13.1 Biogen Inc. Company Detail

11.13.2 Biogen Inc. Business Overview

11.13.3 Biogen Inc. Biosynthesis of Cannabinoids Introduction

11.13.4 Biogen Inc. Revenue in Biosynthesis of Cannabinoids Business (2019-2024)

11.13.5 Biogen Inc. Recent Development

11.14 GW Pharmaceuticals

11.14.1 GW Pharmaceuticals Company Detail

11.14.2 GW Pharmaceuticals Business Overview

11.14.3 GW Pharmaceuticals Biosynthesis of Cannabinoids Introduction

11.14.4 GW Pharmaceuticals Revenue in Biosynthesis of Cannabinoids Business (2019-2024)

11.14.5 GW Pharmaceuticals Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Disclaimer

13.3 Author Details

FEATURED COMPANIES

Anandia Laboratories

Gingko Bioworks

Hyasynth Bio

InMed Pharmaceuticals

Teewinot Life Sciences

ICC International Cannabis Corp.

Biotii Technologies Corp.

Bristol–Myers Squibb

Biogen

GW Pharmaceuticals

List of Tables

Table 1. Global Biosynthesis of Cannabinoids Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030

Table 2. Key Players of THC

Table 3. Key Players of CBD

Table 4. Key Players of Others

Table 5. Global Biosynthesis of Cannabinoids Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030

Table 6. Global Biosynthesis of Cannabinoids Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Table 7. Global Biosynthesis of Cannabinoids Market Size by Region (2019-2024) & (US$ Million)

Table 8. Global Biosynthesis of Cannabinoids Market Share by Region (2019-2024)

Table 9. Global Biosynthesis of Cannabinoids Forecasted Market Size by Region (2025-2030) & (US$ Million)

Table 10. Global Biosynthesis of Cannabinoids Market Share by Region (2025-2030)

Table 11. Biosynthesis of Cannabinoids Market Trends

Table 12. Biosynthesis of Cannabinoids Market Drivers

Table 13. Biosynthesis of Cannabinoids Market Challenges

Table 14. Biosynthesis of Cannabinoids Market Restraints

Table 15. Global Biosynthesis of Cannabinoids Revenue by Players (2019-2024) & (US$ Million)

Table 16. Global Biosynthesis of Cannabinoids Market Share by Players (2019-2024)

Table 17. Global Top Biosynthesis of Cannabinoids Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Biosynthesis of Cannabinoids as of 2023)

Table 18. Ranking of Global Top Biosynthesis of Cannabinoids Companies by Revenue (US$ Million) in 2023

Table 19. Global 5 Largest Players Market Share by Biosynthesis of Cannabinoids Revenue (CR5 and HHI) & (2019-2024)

Table 20. Key Players Headquarters and Area Served

Table 21. Key Players Biosynthesis of Cannabinoids Product Solution and Service

Table 22. Date of Enter into Biosynthesis of Cannabinoids Market

Table 23. Mergers & Acquisitions, Expansion Plans

Table 24. Global Biosynthesis of Cannabinoids Market Size by Type (2019-2024) & (US$ Million)

Table 25. Global Biosynthesis of Cannabinoids Revenue Market Share by Type (2019-2024)

Table 26. Global Biosynthesis of Cannabinoids Forecasted Market Size by Type (2025-2030) & (US$ Million)

Table 27. Global Biosynthesis of Cannabinoids Revenue Market Share by Type (2025-2030)

Table 28. Global Biosynthesis of Cannabinoids Market Size by Application (2019-2024) & (US$ Million)

Table 29. Global Biosynthesis of Cannabinoids Revenue Market Share by Application (2019-2024)

Table 30. Global Biosynthesis of Cannabinoids Forecasted Market Size by Application (2025-2030) & (US$ Million)

Table 31. Global Biosynthesis of Cannabinoids Revenue Market Share by Application (2025-2030)

Table 32. North America Biosynthesis of Cannabinoids Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 33. North America Biosynthesis of Cannabinoids Market Size by Country (2019-2024) & (US$ Million)

Table 34. North America Biosynthesis of Cannabinoids Market Size by Country (2025-2030) & (US$ Million)

Table 35. Europe Biosynthesis of Cannabinoids Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 36. Europe Biosynthesis of Cannabinoids Market Size by Country (2019-2024) & (US$ Million)

Table 37. Europe Biosynthesis of Cannabinoids Market Size by Country (2025-2030) & (US$ Million)

Table 38. Asia-Pacific Biosynthesis of Cannabinoids Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030

Table 39. Asia-Pacific Biosynthesis of Cannabinoids Market Size by Region (2019-2024) & (US$ Million)

Table 40. Asia-Pacific Biosynthesis of Cannabinoids Market Size by Region (2025-2030) & (US$ Million)

Table 41. Latin America Biosynthesis of Cannabinoids Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 42. Latin America Biosynthesis of Cannabinoids Market Size by Country (2019-2024) & (US$ Million)

Table 43. Latin America Biosynthesis of Cannabinoids Market Size by Country (2025-2030) & (US$ Million)

Table 44. Middle East & Africa Biosynthesis of Cannabinoids Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 45. Middle East & Africa Biosynthesis of Cannabinoids Market Size by Country (2019-2024) & (US$ Million)

Table 46. Middle East & Africa Biosynthesis of Cannabinoids Market Size by Country (2025-2030) & (US$ Million)

Table 47. Anandia Laboratories Company Detail

Table 48. Anandia Laboratories Business Overview

Table 49. Anandia Laboratories Biosynthesis of Cannabinoids Product

Table 50. Anandia Laboratories Revenue in Biosynthesis of Cannabinoids Business (2019-2024) & (US$ Million)

Table 51. Anandia Laboratories Recent Development

Table 52. Gingko Bioworks Company Detail

Table 53. Gingko Bioworks Business Overview

Table 54. Gingko Bioworks Biosynthesis of Cannabinoids Product

Table 55. Gingko Bioworks Revenue in Biosynthesis of Cannabinoids Business (2019-2024) & (US$ Million)

Table 56. Gingko Bioworks Recent Development

Table 57. Hyasynth Bio Company Detail

Table 58. Hyasynth Bio Business Overview

Table 59. Hyasynth Bio Biosynthesis of Cannabinoids Product

Table 60. Hyasynth Bio Revenue in Biosynthesis of Cannabinoids Business (2019-2024) & (US$ Million)

Table 61. Hyasynth Bio Recent Development

Table 62. InMed Pharmaceuticals Company Detail

Table 63. InMed Pharmaceuticals Business Overview

Table 64. InMed Pharmaceuticals Biosynthesis of Cannabinoids Product

Table 65. InMed Pharmaceuticals Revenue in Biosynthesis of Cannabinoids Business (2019-2024) & (US$ Million)

Table 66. InMed Pharmaceuticals Recent Development

Table 67. Librede Company Detail

Table 68. Librede Business Overview

Table 69. Librede Biosynthesis of Cannabinoids Product

Table 70. Librede Revenue in Biosynthesis of Cannabinoids Business (2019-2024) & (US$ Million)

Table 71. Librede Recent Development

Table 72. Renew Biopharma Company Detail

Table 73. Renew Biopharma Business Overview

Table 74. Renew Biopharma Biosynthesis of Cannabinoids Product

Table 75. Renew Biopharma Revenue in Biosynthesis of Cannabinoids Business (2019-2024) & (US$ Million)

Table 76. Renew Biopharma Recent Development

Table 77. Cronos Group Company Detail

Table 78. Cronos Group Business Overview

Table 79. Cronos Group Biosynthesis of Cannabinoids Product

Table 80. Cronos Group Revenue in Biosynthesis of Cannabinoids Business (2019-2024) & (US$ Million)

Table 81. Cronos Group Recent Development

Table 82. Organigram Company Detail

Table 83. Organigram Business Overview

Table 84. Organigram Biosynthesis of Cannabinoids Product

Table 85. Organigram Revenue in Biosynthesis of Cannabinoids Business (2019-2024) & (US$ Million)

Table 86. Organigram Recent Development

Table 87. Teewinot Life Sciences Company Detail

Table 88. Teewinot Life Sciences Business Overview

Table 89. Teewinot Life Sciences Biosynthesis of Cannabinoids Product

Table 90. Teewinot Life Sciences Revenue in Biosynthesis of Cannabinoids Business (2019-2024) & (US$ Million)

Table 91. Teewinot Life Sciences Recent Development

Table 92. ICC International Cannabis Corp. Company Detail

Table 93. ICC International Cannabis Corp. Business Overview

Table 94. ICC International Cannabis Corp. Biosynthesis of Cannabinoids Product

Table 95. ICC International Cannabis Corp. Revenue in Biosynthesis of Cannabinoids Business (2019-2024) & (US$ Million)

Table 96. ICC International Cannabis Corp. Recent Development

Table 97. Biotii Technologies Corp. Company Detail

Table 98. Biotii Technologies Corp. Business Overview

Table 99. Biotii Technologies Corp. Biosynthesis of Cannabinoids Product

Table 100. Biotii Technologies Corp. Revenue in Biosynthesis of Cannabinoids Business (2019-2024) & (US$ Million)

Table 101. Biotii Technologies Corp. Recent Development

Table 102. Bristol-Myers Squibb Company Detail

Table 103. Bristol-Myers Squibb Business Overview

Table 104. Bristol-Myers Squibb Biosynthesis of Cannabinoids Product

Table 105. Bristol-Myers Squibb Revenue in Biosynthesis of Cannabinoids Business (2019-2024) & (US$ Million)

Table 106. Bristol-Myers Squibb Recent Development

Table 107. Biogen Inc. Company Detail

Table 108. Biogen Inc. Business Overview

Table 109. Biogen Inc. Biosynthesis of Cannabinoids Product

Table 110. Biogen Inc. Revenue in Biosynthesis of Cannabinoids Business (2019-2024) & (US$ Million)

Table 111. Biogen Inc. Recent Development

Table 112. GW Pharmaceuticals Company Detail

Table 113. GW Pharmaceuticals Business Overview

Table 114. GW Pharmaceuticals Biosynthesis of Cannabinoids Product

Table 115. GW Pharmaceuticals Revenue in Biosynthesis of Cannabinoids Business (2019-2024) & (US$ Million)

Table 116. GW Pharmaceuticals Recent Development

Table 117. Research Programs/Design for This Report

Table 118. Key Data Information from Secondary Sources

Table 119. Key Data Information from Primary Sources

List of Figures

Figure 1. Global Biosynthesis of Cannabinoids Market Size Comparison by Type (2024-2030) & (US$ Million)

Figure 2. Global Biosynthesis of Cannabinoids Market Share by Type: 2023 VS 2030

Figure 3. THC Features

Figure 4. CBD Features

Figure 5. Others Features

Figure 6. Global Biosynthesis of Cannabinoids Market Size Comparison by Application (2024-2030) & (US$ Million)

Figure 7. Global Biosynthesis of Cannabinoids Market Share by Application: 2023 VS 2030

Figure 8. Food Industry Case Studies

Figure 9. Medical Industry Case Studies

Figure 10. Others Case Studies

Figure 11. Biosynthesis of Cannabinoids Report Years Considered

Figure 12. Global Biosynthesis of Cannabinoids Market Size (US$ Million), Year-over-Year: 2019-2030

Figure 13. Global Biosynthesis of Cannabinoids Market Size, (US$ Million), 2019 VS 2023 VS 2030

Figure 14. Global Biosynthesis of Cannabinoids Market Share by Region: 2023 VS 2030

Figure 15. Global Biosynthesis of Cannabinoids Market Share by Players in 2023

Figure 16. Global Top Biosynthesis of Cannabinoids Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Biosynthesis of Cannabinoids as of 2023)

Figure 17. The Top 10 and 5 Players Market Share by Biosynthesis of Cannabinoids Revenue in 2023

Figure 18. North America Biosynthesis of Cannabinoids Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 19. North America Biosynthesis of Cannabinoids Market Share by Country (2019-2030)

Figure 20. United States Biosynthesis of Cannabinoids Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 21. Canada Biosynthesis of Cannabinoids Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 22. Europe Biosynthesis of Cannabinoids Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 23. Europe Biosynthesis of Cannabinoids Market Share by Country (2019-2030)

Figure 24. Germany Biosynthesis of Cannabinoids Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 25. France Biosynthesis of Cannabinoids Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 26. U.K. Biosynthesis of Cannabinoids Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 27. Italy Biosynthesis of Cannabinoids Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 28. Russia Biosynthesis of Cannabinoids Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 29. Nordic Countries Biosynthesis of Cannabinoids Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 30. Asia-Pacific Biosynthesis of Cannabinoids Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 31. Asia-Pacific Biosynthesis of Cannabinoids Market Share by Region (2019-2030)

Figure 32. China Biosynthesis of Cannabinoids Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 33. Japan Biosynthesis of Cannabinoids Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 34. South Korea Biosynthesis of Cannabinoids Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 35. Southeast Asia Biosynthesis of Cannabinoids Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 36. India Biosynthesis of Cannabinoids Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 37. Australia Biosynthesis of Cannabinoids Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 38. Latin America Biosynthesis of Cannabinoids Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 39. Latin America Biosynthesis of Cannabinoids Market Share by Country (2019-2030)

Figure 40. Mexico Biosynthesis of Cannabinoids Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 41. Brazil Biosynthesis of Cannabinoids Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 42. Middle East & Africa Biosynthesis of Cannabinoids Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 43. Middle East & Africa Biosynthesis of Cannabinoids Market Share by Country (2019-2030)

Figure 44. Turkey Biosynthesis of Cannabinoids Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 45. Saudi Arabia Biosynthesis of Cannabinoids Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 46. Anandia Laboratories Revenue Growth Rate in Biosynthesis of Cannabinoids Business (2019-2024)

Figure 47. Gingko Bioworks Revenue Growth Rate in Biosynthesis of Cannabinoids Business (2019-2024)

Figure 48. Hyasynth Bio Revenue Growth Rate in Biosynthesis of Cannabinoids Business (2019-2024)

Figure 49. InMed Pharmaceuticals Revenue Growth Rate in Biosynthesis of Cannabinoids Business (2019-2024)

Figure 50. Librede Revenue Growth Rate in Biosynthesis of Cannabinoids Business (2019-2024)

Figure 51. Renew Biopharma Revenue Growth Rate in Biosynthesis of Cannabinoids Business (2019-2024)

Figure 52. Cronos Group Revenue Growth Rate in Biosynthesis of Cannabinoids Business (2019-2024)

Figure 53. Organigram Revenue Growth Rate in Biosynthesis of Cannabinoids Business (2019-2024)

Figure 54. Teewinot Life Sciences Revenue Growth Rate in Biosynthesis of Cannabinoids Business (2019-2024)

Figure 55. ICC International Cannabis Corp. Revenue Growth Rate in Biosynthesis of Cannabinoids Business (2019-2024)

Figure 56. Biotii Technologies Corp. Revenue Growth Rate in Biosynthesis of Cannabinoids Business (2019-2024)

Figure 57. Bristol-Myers Squibb Revenue Growth Rate in Biosynthesis of Cannabinoids Business (2019-2024)

Figure 58. Biogen Inc. Revenue Growth Rate in Biosynthesis of Cannabinoids Business (2019-2024)

Figure 59. GW Pharmaceuticals Revenue Growth Rate in Biosynthesis of Cannabinoids Business (2019-2024)

Figure 60. Bottom-up and Top-down Approaches for This Report

Figure 61. Data Triangulation

Figure 62. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

RELATED REPORTS

Global Controlled Release Cannabis Pills Market Research Report 2024

120 Pages

Type: Report

Code: QYRE-Auto-1V9558

Mon Apr 15 00:00:00 UTC 2024

Add to Cart

Global White Label E-Liquid Market Research Report 2024

120 Pages

Type: Report

Code: QYRE-Auto-1K9516

Tue Apr 02 00:00:00 UTC 2024

Add to Cart

Global BF3 Complexes Market Research Report 2024

120 Pages

Type: Report

Code: QYRE-Auto-11M17070

Wed Mar 27 00:00:00 UTC 2024

Add to Cart

Global Live Resin Vape Cart Market Research Report 2024

120 Pages

Type: Report

Code: QYRE-Auto-20R16931

Wed Mar 27 00:00:00 UTC 2024

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions